Ultra-Low B Cell Detection: Flow Cytometry Method Validation to 10 cells/μL
Learn how Resolian developed a validated flow cytometry method achieving B cell detection down to 0.5 cells/μL with 5.27% CV using innovative matrix design.
Learn how Resolian developed a validated flow cytometry method achieving B cell detection down to 0.5 cells/μL with 5.27% CV using innovative matrix design.
Extraction method drastically affects elemental analysis results. Resolian’s comparison shows simulated-use extraction provides realistic risk assessment vs total digestion.
Chiral method development is unpredictable and time-consuming. Resolian’s SFC workflow with Design of Experiments reduces workload while improving efficiency
Resolian signs a nonexclusive strategic partnership agreement with GoBroad Healthcare Group, a China-based, clinically focused innovation technology platform and Academic Research Organization (ARO).
How do you verify E&L screening readiness? Resolian developed a USP-based 15-compound system suitability standard ensuring UPLC-HRMS methods are fit for purpose.
When complex matrices and no internal standard threaten ultra-trace analysis, Resolian’s online SPE approach achieves sub-ng/mL NDSRI quantification in GMP.
Resolian works alongside drug developers as a trusted guide, delivering nitrosamine testing data to support confident risk decisions.
Proud to see Resolian’s permeability studies acknowledged in groundbreaking research published in the Journal of Medicinal Chemistry.
What if your purification resin introduces impurities? Resolian’s multi-technique approach detects organic and inorganic PERLs from commercially available resins.
Ion-pair reagents contaminate systems and reduce sensitivity. Resolian’s nSEC-MS method characterizes oligonucleotides in 7.5 minutes without ion-pairing agents.